IP Library Granted Patent US 7,220,872
Granted Patent B2
US 7,220,872 · App. 10/510,120 · Granted May 22, 2007

Conversion of taxane molecules

Assignee: Natural Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,220,872
App. No.
10/510,120
Granted
May 22, 2007
Kind
B2
Abstract

The invention provides methods and compositions for reductively deoxygenating an amide group at a C-3′ position of a taxane molecule followed by subsequent intra-molecular acyl migration of an acyl group to the C-3′ position.

Claims (74)

1. A method of converting a taxane molecule having the formula:

wherein

R 1 is hydrogen, an alkyl group, an aryl group, an ester group, an ether group, or a hydroxyl protecting group;

R 2 is hydrogen, an alkyl group, an aryl group, an ester group, an ether group, or a hydroxyl protecting group;

R 4 is hydrogen, an alkyl group, an aryl group, an ester group, an ether group, or a hydroxyl protecting group;

R 7 is hydrogen, an alkyl group, an aryl group, an ester group, an ether group, a glycoside group, an oxo-group, or a hydroxyl protecting group;

R 10 is hydrogen, an alkyl group, an aryl group, an ester group, an ether group, or a hydroxyl protecting group;

R is an alkoxy group, an alkyl group, an aryl group, an arylalkyl group, an ether group, heterocyclic group, or a vinyl group; and

R N is an alkoxy group, an alkyl group, an aryl group, an arylalkyl group, an ether group, or a heterocyclic group, or a vinyl group;

the method comprising the steps of:

reductively deoxygenating the C-3′ amide group on the taxane molecule to form an a C-3′ imine compound;

hydrolyzing the imine compound to form a primary amine compound; and

treating the primary amine compound with a hindered base capable of effecting acyl migration to form another taxane molecule having the formula:

wherein

R 1 , R 2 , R 4 , R 7 , R 10 , and R N are as defined above.

2. The method of claim 1 wherein the step of reductively deoxygenating the C-3′ amide group on the taxane compound comprises contacting the taxane compound with a transition metal reducing agent.

3. The method of claim 2 , wherein the transition metal reducing agent is Schwartz's reagent (zirconocene chloride hydride).

4. The method of claim 2 , wherein the transition metal reducing agent is an analogue or derivative of Schwartz's reagent.

5. The method of claim 2 , wherein the transition metal reducing agent is selected from the group consisting of titanium-containing reducing agents, hafnium-containing reducing agents, niobium-containing reducing agents, and molybdenum-containing reducing agents.

6. The method of claim 1 wherein the step of hydrolyzing the imine compound comprises contacting the imine compound with an acid.

7. The method of claim 6 wherein the acid is sulfuric acid.

8. The method of claim 1 wherein the step of treating the primary amine compound with a base comprises treating the primary amine compound with triethylamine.

9. The method of claim 1 wherein the step of treating the primary amine compound with a base comprises treating the primary amine compound with triethylamine and anthranilic acid.

10. The method of claim 1 , further comprises the step of chelating the transition metal reducing agent or by-products thereof by adding a chelating agent.

11. The method of claim 1 , wherein the chelating step comprises chelating the transition metal reducing agent or by-products thereof with a zirconium chelator.

12. The method of claim 11 , wherein the chelating step comprises chelating the transition metal reducing agent or by-products thereof with N,N-bis(2-hydroxyethyl) glycine (bicine).

13. The method of claim 11 , wherein the chelating step comprises chelating the transition metal reducing agent or by-products thereof with an agent comprising a chelating agent selected from the group consisting of ethylene diamine tetra acetic acid (EDTA), ethylene glycol (bis) aminoethyl ether tetra acetic acid (EGTA), 1,2-bis-(o-aminophenoxy) ethane-N,N,N′,N′-tetra-acetic acid (BAPTA), N,N,N′,N′-tetrakis-(2-pyridylmethyl) ethylenediamine (TPEN), nitrilotriacetic acid, TIRON® and analogues and derivatives thereof.

14. The method of claim 1 wherein the imine compound and the primary amine compound are not isolated prior to the next step.

15. The method of claim 1 wherein R N is phenyl, 1-methyl-1-propenyl, n-pentyl, propyl, 1-methyl-propyl, benzyl, 2-furanyl, ortert-butoxy.

16. A method of converting a taxane molecule having the formula:

wherein

R 1 is hydrogen;

R 2 is a benzoyl group;

R 4 is an acetate group;

R 7 is hydrogen;

R 10 is hydrogen or an acetate group;

R is an alkoxy group, an alkyl group, an aryl group, an arylalkyl group, an ether group, heterocyclic group, or a vinyl group; and

R N is phenyl, 1-methyl-1-propenyl, n-pentyl, propyl, 1-methyl-propyl, benzyl, 2-furanyl, or tert-butoxy;

the method comprising the steps of:

reacting the taxane molecule with zirconocene chloride hydride in a solvent to form an imine compound;

hydrolyzing the imine compound to form a primary amine compound; and

treating the primary amine compound with a base to form another taxane molecule having the formula:

wherein

R 1 , R 2 , R 4 , R 7 , R 10 , and R N are as defined above.

17. The method of claim 16 wherein the step of reacting the taxane molecule comprises reacting the taxane molecule with about 3 or more molar equivalents of zirconocene chloride hydride.

18. The method of claim 17 wherein reacting the taxane molecule with zirconocene chloride hydride comprises reacting the taxane molecule with zirconocene chloride hydride at a temperature below about 15° C.

19. The method of claim 16 wherein the solvent is tetrahydrofuran.

20. The method of claim 16 wherein the step of hydrolyzing the imine compound comprises treating the imine compound with an acid.

21. The method of claim 20 , wherein the step of hydrolyzing the imine compound comprises treating the imine compound with sulfuric acid.

22. The method of claim 16 , wherein the step of treating the primary amine compound with a base comprises treating the primary amine compound with triethylamine.

23. The method of claim 16 , wherein the step of treating the primary amine compound with base comprises treating the primary amine compound with triethylamine and anthranilic acid.

24. The method of claim 16 comprising the step of chelating the zirconocene chloride hydride and other zirconium by-products prior to hydrolyzing the imine compound with a chelating agent.

25. The method of claim 16 , wherein the chelating step comprises chelating the transition metal reducing agent or by-products thereof with N,N-bis(2-hydroxyethyl) glycine (bicine).

26. The method of claim 16 , wherein the chelating step comprises chelating the transition metal reducing agent or by-products thereof with an agent comprising a chelating agent selected from the group consisting of ethylene diamine tetra acetic acid (EDTA), ethylene glycol (bis) aminoethyl ether tetra acetic acid (EGTA), 1,2-bis-(o -aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA), N,N,N′,N′-tetrakis-(2-pyridylmethyl) ethylenediamine (TPEN), nitrilotriacetic acid, TIRON® and analogues and derivatives thereof.

27. The method of claim 16 wherein R 10 is hydrogen.

28. The method of claim 27 wherein R N is phenyl, and R is phenyl, 1-methyl-1-propenyl, n-pentyl, propyl, 1-methyl-propyl, benzyl, 2-furanyl, or tert-butoxy.

29. The method of claim 27 wherein R N is 1-methyl-1-propenyl, and R is phenyl, 1-methyl-1-propenyl, n-phetyl, propyl, 1-methyl-propyl, benzyl, 2-furanyl, or tert butoxy.

30. The method of claim 27 wherein R N is n-pentyl, and R is phenyl, 1-methyl-1-propenyl, n-pentyl, propyl, 1-methyl-propyl, benzyl, 2-furanyl, or tert-butoxy.

31. The method of claim 16 wherein R 10 is an acetate group.

32. The method of claim 31 wherein R N is phenyl, and R is phenyl, 1-methyl-1-propenyl, n-pentyl, propyl, 1-methyl-propyl, benzyl, 2-furanyl, or tert-butoxy.

33. The method of claim 31 wherein R N is 1-methyl-1-propenyl, and R is phenyl, 1-methyl-1-propenyl, n-phetyl, propyl, 1-methyl-propyl, benzyl, 2-furanyl, or tert butoxy.

34. The method of claim 31 wherein R N is n-pentyl, and R is phenyl, 1-methyl-1-propenyl, n-pentyl, propyl, 1-methyl-propyl, benzyl, 2-furanyl, or tert-butoxy.

35. The method of claim 34 , further comprises the step of dictating the zirconocene chloride hydride and other zirconium by-products thereof by adding a chelating agent.

36. The method of claim 35 , wherein the chelating step comprises adding zirconium chelator.

37. The method of claim 35 , wherein the chelating step comprises chelating the transition metal reducing agent or by-products thereof with N,N-bis(2-hydroxyethyl)glycine(bicine).

38. The method of claim 35 , wherein the chelating step comprises adding a chelating agent comprising a chelating agent selected from the group consisting of ethylene diamine tetra acetic acid (EDTA), ethylene glycol (bis) aminoethyl ether tetra acetic acid (EGTA), 1,2-bis-(O-aminophenoxy) ethane-N,N,N′,N′-tetra-acetic acid (BAPTA), N,N,N′,N′-tetrakis-(2-pyridylmethyl)ethylenediamine (TPEN), nitrilotriacetic acid, TIRON® or analogues thereof.

39. The method of claims 1 or 16 , further comprising the step of removing substantially all of the transition metal or transition metal by-products by complexation, precipitation, filtration, centrifugation, electrochemical methodology, chromatography, chelation or any combination thereof.

40. A method of converting an acyl-protected taxane molecule, the method comprising the steps of:

reductively deoxygenating an amide group on the taxane molecule to form an imine compound;

hydrolyzing the imine compound to form a primary amine compound; and

treating the primary amine compound with a hindered base capable of effecting acyl migration to form another taxane molecule.

41. The method of claim 40 , wherein the step of reductively deoxygenating an amide group on the taxane compound comprises conducting the taxane compound with a transition metal reducing agent.

42. The method of claim 40 , wherein the step of hydrolyzing the imine compound comprises contacting the imine compound with an acid.

43. The method of claim 40 , wherein the step of treating the primary amine compound with a base comprises treating the primary amine compound with triethylamine.

Assignments (6)
CHANGE OF NAME Recorded Jan 14, 2010
From: PHYTON, INC.
To: PHYTON HOLDINGS, LLC
Reel/Frame 023786/0389 →
CHANGE OF NAME Recorded Jan 14, 2010
From: PHYTON, INC.
To: PHYTON HOLDINGS, LLC
Reel/Frame 023786/0690 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2010
From: NATURAL PHARMA CANADA, ULC; NATURAL PHARMACEUTICALS, INC.
To: PHYTON, INC.
Reel/Frame 023768/0757 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2010
From: NATURAL PHARMA CANADA, ULC; NATURAL PHARMACEUTICALS, INC.
To: PHYTON, INC.
Reel/Frame 023768/0626 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2010
From: NATURAL PHARMA CANADA, ULC; NATURAL PHARMACEUTICALS, INC.
To: PHYTON, INC.
Reel/Frame 023741/0771 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2004
From: JOHNSON, JAMES H.; GALLAGHER, REX T.; FRANKE, ROLAND R.
To: NATURAL PHARMACUETICALS, INC.
Reel/Frame 016749/0083 →
Continuity (2)
Provisional Application 6037058300 · Apr 5, 2002
Related Publication 20050234249A1 · Oct 20, 2005